FDA approves most expensive drug in the WORLD - $3.5m therapy for hemophilia B

The US has approved Hemgenix - a one-time intravenous treatment for hemophilia B, a disorder in which people do not produce a protein needed to create blood clots and control bleeding.

Related Keywords

Novartis Zolgensma ,Brad Loncar ,Bloomberg ,Drug Administration ,Loncar Investments ,Classic Hemophilia ,Christmas Disease ,Dailymail ,Health ,